0001567619-22-001334.txt : 20220119 0001567619-22-001334.hdr.sgml : 20220119 20220119183431 ACCESSION NUMBER: 0001567619-22-001334 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220114 FILED AS OF DATE: 20220119 DATE AS OF CHANGE: 20220119 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LAWLIS V BRYAN CENTRAL INDEX KEY: 0001247681 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26727 FILM NUMBER: 22540047 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOMARIN PHARMACEUTICAL INC CENTRAL INDEX KEY: 0001048477 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 680397820 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 BUSINESS PHONE: 4155066700 MAIL ADDRESS: STREET 1: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 4 1 doc1.xml FORM 4 X0306 4 2022-01-14 0 0001048477 BIOMARIN PHARMACEUTICAL INC BMRN 0001247681 LAWLIS V BRYAN C/O BIOMARIN PHARMACEUTICAL INC. 105 DIGITAL DRIVE NOVATO CA 94949 1 0 0 0 Common Stock 2022-01-14 4 M 0 4250 37.46 A 28220 D Common Stock 2022-01-14 4 S 0 4250 87.61 D 23970 D Stock Option (Right to buy Common Stock) 37.46 2022-01-14 4 M 0 4250 0 D 2012-11-08 2022-05-07 Common Stock 4250 4250 D Trade made pursuant to a 10b5-1 plan executed on July 29, 2021. Reflects the number of options outstanding after the transactions from this specific stock option grant. /s/ Eric Fleekop, Attorney-in-Fact 2022-01-19